Business
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
Spectral Flow Cytometry Pioneer Unveils Innovations Accelerating Efficiency and DiscoveryFREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) will showcase its advanced, high-parameter solutions at two notable industry events later this month: the European Society for Clinical Cell Analysis (ESCCA) 2025 Conference and ICCS 2025, the 40th
About this update from Cytek Biosciences, Inc.
[{"type":"image","alt":"Cytek Biosciences, Inc.","displaySize":"","headline":null,"caption":"Cytek Biosciences, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":94,"url":"https://media.zenfs.com/en/globenewswire.com/bc3b354d3f50b53d40b4edfe89e7fd8f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3p0SVRz3IvMSXP918Y7IYw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/bc3b354d3f50b53d40b4edfe89e7fd8f","width":300,"height":94}},"lazy":false},{"type":"text","content":"Spectral Flow Cytometry Pioneer Unveils Innovations Accelerating Efficiency and Discovery","length":89,"tagName":"p"},{"type":"text","content":"FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) will showcase its advanced, high-parameter solutions at two notable industry events later this month: the European Society for Clinical Cell Analysis (ESCCA) 2025 Conference and ICCS 2025, the 40th Annual International Clinical Cytometry Meeting & Course.","length":478,"tagName":"p"},{"type":"text","content":"Set apart from traditional flow cytometry approaches, Cytek’s distinctive Full Spectrum Profiling™ (FSP®) technology has profoundly changed the understanding of cell biology, immunology, oncology, and targeted therapeutic methodologies – leading to streamlined workflows, accelerated discovery, and enhanced efficiency. The company’s FSP systems have become the spectral technology of choice for researchers worldwide, with more than 2,800 peer-reviewed publications citing their use.","length":484,"tagName":"p"},{"type":"text","content":"ESCCAAs a leading forum for scientific exchange in flow cytometry, ESCCA focuses on clinical applications in hematology, immunology, cancer, and cell biology. ESCCA 2025 will be held in Montpellier, France, from September 17, 2025 through September 20, 2025, and will attract a global audience of clinicians and researchers.","length":325,"tagName":"p"},{"type":"text","content":"At the conference, Cytek will showcase its comprehensive end-to-end cell analysis solutions, designed to empower clinicians and researchers with deeper scientific insights, enable faster data-driven decision-making, and drive accelerate...